Category: Mesothelioma News
The Ketogenic Diet Could be used to Slow Cancer Growth
According to a study done at The University of Texas at Dallas, the Ketogenic diet, which is very low in sugar, as well as the administration of a diabetes drug that prevents glucose in the blood from being adsorbed by the kidneys, slowed down the growth of squamous cell carcinoma tumors in mice. This specific
MD Anderson Remains Top-Ranked Cancer Center
U.S. News & World Report named University of Texas MD Anderson Cancer Center in Houston as the No. 1 Adult Cancer Hospital in America for the fifth consecutive year. Memorial Sloan-Kettering Cancer Center in New York, Mayo Clinic in Rochester, Minnesota, Johns Hopkins Hospital in Baltimore and Dana-Farber/Brigham and Women’s Cancer Center in Boston, round…
The post MD Anderson Remains Top-Ranked Cancer Center appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
Mesothelioma Study Explores New Treatment When Chemotherapy Fails
A clinical trial is exploring whether a novel immunotherapy/antiangiogenic combination can serve as an effective second-line treatment for pleural mesothelioma. Early indications of the four-center, phase II clinical trial are positive. The combination involves nivolumab (Opdivo) , a well-known immunotherapy drug, and ramucirumab (Cyramza), a therapy drug that blocks the formation of blood vessels needed…
The post Mesothelioma Study Explores New Treatment When Chemotherapy Fails appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
White House Asbestos Risk Forces Top Staff Relocation
The offices of some of President Donald Trump’s top aides, including his daughter Ivanka Trump and senior counselor Kellyanne Conway, have been temporarily relocated as the White House undergoes asbestos abatement work. An asbestos removal project is underway at 1600 Pennsylvania Avenue and is expected to be completed by the end of August. The abatement…
The post White House Asbestos Risk Forces Top Staff Relocation appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
Opdivo and MTG201 Together Could Potentially Treat Mesothelioma
Typical cancer treatments are hard on the body and are not always effective. When treating someone for cancer, chemotherapy is typically used, which kills cancer cells or stops them from growing or spreading. Chemotherapy can also kill healthy cells, which makes it hard on the body. Immunotherapy is another option, and it works by helping
Dendritic Cell Therapy Could be used to Treat Mesothelioma
Immunotherapy is a blossoming field that is becoming more advanced. Instead of other treatments that kill healthy cells in addition to killing cancerous cells, immunotherapy uses the body’s immune system to fight cancer cells, leaving healthy non-cancerous cells intact. It is a better treatment because it is very effective, more efficient, and is easier on
Clinical Trial Offering Personalized Immunotherapy for Mesothelioma
Patients with mesothelioma are now eligible for a multicancer clinical trial studying the effectiveness of personalized immunotherapy at the University of California, San Diego Medical Center. The phase I clinical trial involves a combination of Keytruda (pembrolizumab), a proven immunotherapy drug, and an individualized vaccine based upon the genetic mutations found in each patient’s cancer….
The post Clinical Trial Offering Personalized Immunotherapy for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.